Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like ABB and SUSI partner for microgrid and energy storage projects January 31, 2019 Abaco Systems introduces VP430 Direct RF Processing System April 3, 2018 HIMA talks functional safety concepts at ARC Industry Forum February 22, 2018